Cannabidiol
The second most common phytocannibanoid
Click on a study title below to open a new tab with full article.
Uses Title Date
cns disorders
Phytocannabinoids as novel therapeutic agents in CNS disorders Jan 2012
epilepsy
Cannabidiol and epilepsy: Rationale and therapeutic potential May 2016
anti-inflamatory
Cannabinoids suppress inflammatory and neuropathic pain by targeting Alpha3 glycine receptors June 2012
opiate addiction
Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage Aug 2015
epilepsy
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders May 2014
cancer
Cannabidiol as potential anticancer drug April 2012
anxiety
Cannabidiol as a Potential Treatment for Anxiety Disorders Sept 2015
diabetes
Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes. 2016
acne
Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes July 2014
anti-inflamatory
arthritis
Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis May 2014
pain
arthritis
Cannabinoid CB2 receptors regulate central sensitization and pain responses associated with osteoarthritis of the knee joint. Nov 2013
pain
arthritis
Involvement of the endocannabinoid system in osteoarthritis pain. Feb 2014
autism
Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities Jan 2019
epilepsy
CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience. Feb 2016
anti-psychotic
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Apr 2006
autism
Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems-A Retrospective Feasibility Study. Oct 2018
autism
Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy Jan 2019
stroke
Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke Jun 2010
depression
Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex. Jun 2018
depression
Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors. Apr 2016
anti-psychotic
Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists. Mar 2010
alzheimers
Cannabidiol Modulates the Expression of Alzheimer's Disease-Related Genes in Mesenchymal Stem Cells. Dec 2016
cancer
breast cancer
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti?tumor mechanisms of Cannabidiol in breast cancer Jan 2015
cancer
breast cancer
Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis. Aug 2011
cancer
breast cancer
Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells. Nov 2007
cancer
breast cancer
Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. May 2006
cancer
breast cancer
Novel mechanism of cannabidiol-induced apoptosis in breast cancer cell lines. Oct 2018
cancer
breast cancer
prostate cancer
Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas. Nov 2016
neurogenesis
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system Jul 2013
ptsd
Cannabidiol as a Therapeutic Alternative for Post-traumatic Stress Disorder: From Bench Research to Confirmation in Human Trials Jul 2018
cancer
Delta(9) -tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature. May 2015
inflamatory bowel disease
anti-inflamatory
An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse Oct 2016
appetite supress
Cannabinol and cannabidiol exert opposing effects on rat feeding patterns. Sept 2012
vasoralaxant
anti-inflamatory
Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation Sept 2015
appetite supress
Cannabidiol Attenuates the Appetitive Effects of ?9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis Aug 2010
ovarian cancer
Evaluation of the effects of cannabinoids CBD and CBG on human ovarian cancerc ells in vitro Jan 2019
cancer
melanoma
Cannabinoids as a Potential New and Novel Treatment for Melanoma: A Pilot Study in a Murine Model. Mar 2019
cancer
prostate cancer
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms Jan 2013